Nihal Mostafa

Nihal Mostafa

Auto-generated profile, based on publicly available information

Nihal Mostafa

Lecturer of Biochemistry, Faculty of Science, Ain Shams University, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Technology in Cancer Research & Treatment
Verified
Journal Article
Open access
NMNihal Mostafa
Nihal Mostafa
ASAhmed Salem
Ahmed Salem
SMSomaya Z. Mansour
Somaya Z. Mansour
SESawsan M. El-Sonbaty
Sawsan M. El-Sonbaty
FMFatma S. M. Moawed
Fatma S. M. Moawed
EKEman I. Kandil
Eman I. Kandil
Introduction: In the fight against cancer, cisplatin is most widely used as a clinical mainstay for the chemotherapy of various human cancers. Meanwhile, its cytotoxic profile, as well as drug resistance, limits its widespread application. The goal of precision medicine is to tailor an optimized therapeutic program based on the biology of the disease. Recently, nanotechnology has been demonstrated to be promising in this scenario. Objective: The current work provides a rationale for the design of an alternative oncology trial for the treatment of hepatocarcinogenesis using a novel eco-friendly nanocomplex, namely gallic acid-coated gallium nanoparticles. Moreover, the study tests whether the antineoplastic efficacy of gallic acid-coated gallium nanoparticles could be enhanced or not when it is administrated together with cisplatin. Methods: The work comprised a series of both in vitro and in vivo investigations. The in vivo therapeutic efficacy of such treatments, against diethylnitrosamine-induced hepatocarcinogenesis, was strictly evaluated by tracking target genes expressions, iron homeostasis, diverse biomarkers alterations, and lastly, routine paraclinical investigations were also assessed. Results: The in vitro biological evaluation of gallic acid-coated gallium nanoparticles in a HepG-2 cancer cell line established its superior cytotoxicity. Else more, the results of the in vivo experiment highlighted that gallic acid-coated gallium nanoparticles could diminish key hallmarks of cancer by ameliorating most of the investigated parameters. This was well-appreciated with the histopathological findings of the liver architectures of the treated groups. Conclusions: Our findings suggest that novel biogenic Ga-based nanocomplexes may potentially present new hope for the development of alternative liver cancer therapeutics, which should attract further scientific interest.

11 February 2025 in Journal of lasers in medical sciences
Verified
Journal Article
Open access
PDF file
AAAhmed Mamdouh Abdelkader
Ahmed Mamdouh Abdelkader
ATAhmed Ali Mohammed Torad
Ahmed Ali Mohammed Torad
MEMohamed Ahmed Elbedewy
Mohamed Ahmed Elbedewy
NMNihal Mostafa
Nihal Mostafa
ASAmr Saadeldeen Mohamed Shalaby
Amr Saadeldeen Mohamed Shalaby
AAAlaa Anwar Ahmed
Alaa Anwar Ahmed
Introduction: All three degrees of inflammation (cellular, tissue, and systemic) are normal reactions that our bodies have to foreign substances. Cellular damage from bacteria, viruses, and even cancer can be warded off with the aid of these reactions. An efficient non-pharmaceutical method of treating inflammation is frequently seen as physiotherapy. In this study, the effects of ultrasonic treatment (US) and low-level laser therapy (LLLT) on the levels of C-reactive protein (CRP) in rats with inflamed testicles are investigated. Methods: Three groups, each including eighteen male rats, were established: the control group (C), the US group (which received ultrasonic treatment), and the LLLT group (which received low-level laser therapy). Results: The blood CRP levels in the US group were significantly lower than those in the control and LLLT groups. Conclusion: Findings suggest that ultrasound might be more effective than LLLT in treating testicular inflammation, as shown by the decrease in blood CRP levels.